{"id":"W2220471922","doi":"10.2217/mmt.15.13","title":"Oncolytics Biotech <sup>®</sup> Inc.: REOLYSIN <sup>®</sup> for Melanoma Therapy","year":2015,"lang":"en","type":"editorial","venue":"Melanoma Management","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Cancer therapy; Melanoma; Cancer; Virology; Cancer research; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002490315,0.001335111,0.001202165,0.0006025897,0.0003642527,0.000343534,0.002469279,0.002279063,0.0001773373],"category_scores_gemma":[0.0002948269,0.001299135,0.0006298208,0.0004859054,0.0002863673,0.00001946314,0.001141402,0.001001354,0.000290974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005521547,"about_ca_system_score_gemma":0.0008489476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009293515,"about_ca_topic_score_gemma":0.00006156295,"domain_scores_codex":[0.9924929,0.0004856791,0.001115876,0.002215636,0.002045874,0.001644081],"domain_scores_gemma":[0.9950358,0.0001962839,0.0004662695,0.002943742,0.0008695108,0.0004884514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005981393,0.0004463118,0.00001780509,0.0002888975,0.001894127,0.00009147949,0.0001534119,0.001244146,0.001846314,0.00004138319,0.949724,0.03827078],"study_design_scores_gemma":[0.005794308,0.008145311,0.000003915452,0.00009175246,0.0002287439,0.000005335788,0.0002575298,0.001467646,0.01563348,0.0002534422,0.9667748,0.001343741],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.2152972,0.05140082,0.01024078,0.004609962,0.6288148,0.03829435,0.01165047,0.001395699,0.03829594],"genre_scores_gemma":[0.01395103,0.01570206,0.005213117,0.0009533949,0.8586659,0.003601311,0.02477728,0.0012983,0.07583762],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.2298511,"threshold_uncertainty_score":0.99994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02150293345390318,"score_gpt":0.3040468738097407,"score_spread":0.2825439403558375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}